CardioGenics Holdings Inc. reported earnings results for the third quarter and nine months ended July 31, 2013. For the third quarter, the company reported net loss attributable to the company of CAD 315,428, compared to a net loss attributable to the company of CAD 237,434, for the third quarter ended July 31, 2012. Operating loss for the third quarter ended July 31, 2013 was CAD 233,624, compared to an operating loss of CAD 234,340, for the third quarter ended July 31, 2012.

Net loss attributable to the company for the nine months ended July 31, 2013 was CAD 757,094, or CAD 0.01 loss per share, compared to a net loss attributable to the company of CAD 944,106, or CAD 0.02 loss per share, for the nine months ended July 31, 2012. Operating loss for the nine months ended July 31, 2013 was CAD 648,153, compared to an operating loss of CAD 955,084, for the nine months ended July 31, 2012.